Cargando…
Current findings for recurring mutations in acute myeloid leukemia
The development of acute myeloid leukemia (AML) is a multistep process that requires at least two genetic abnormalities for the development of the disease. The identification of genetic mutations in AML has greatly advanced our understanding of leukemogenesis. Recently, the use of novel technologies...
Autor principal: | Takahashi, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180439/ https://www.ncbi.nlm.nih.gov/pubmed/21917154 http://dx.doi.org/10.1186/1756-8722-4-36 |
Ejemplares similares
-
Combination Therapies with Kinase Inhibitors for Acute Myeloid Leukemia Treatment
por: Takahashi, Shinichiro
Publicado: (2023) -
Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications
por: Takahashi, Shinichiro
Publicado: (2011) -
Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions
por: Fedorov, Kateryna, et al.
Publicado: (2023) -
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
por: Zarka, Jabra, et al.
Publicado: (2020) -
Acute Myeloid Leukemia Mutations: Therapeutic Implications
por: Papayannidis, Cristina, et al.
Publicado: (2019)